Company ProfileSeamless XR develops medical devices for sensory rehabilitation.Our lead product, Artemis, uses patented micro-haptic (pneumatic “air bubble”) tech to objectively assess sensory deficits in patients with neurological injuries arising from stroke and other conditions, like stroke or spinal cord injury as well as carpal tunnel syndrome. Unlike manual sensory tests, Artemis standardizes and speeds up the process—delivering results in under 10 minutes and generating quantifiable, trackable data for clinicians. The system is designed for use in hospitals and rehab centers, supports both therapist-led and automated self-assessment modes, and can be integrated with digital health workflows.This is a significant leap over the "state-of-art" method, which is still entirely manual and requires tedious testing and manual data logging. This means that sensory rehab is largely ignored with only ~40% therapists conducting sensory assessments regularly, and most using non-standard methods. This naturally leads to worse patient outcomes, lower independence and low rates of patients returning to the workforce.We're piloting with NUHS with a clinical PI, and are backed by NUS GRIP, NAMIC, and Medtech Actuator.The next goal is conducting a clinical trial validating the use of Artemis as non just a diagnostic, but a therapeutic intervention tool for sensory rehabilitation.Key Highlights:-Patented Pneumatic Haptics-Proprietary Assessment Algorithm-NUS GRIP Spinoff, supported by NAMIC-MedTech Actuator Origin 2025 Finalist